Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled pilot study investigating signals involved in drug resistance
to chemotherapy.
Patient will be randomized to undergo observation or to receive Everolimus after completion
of neoadjvuant treatment (anthracycline and/or taxane-based) and before surgery. The patients
will be monitored for efficacy and safety.
Phase:
Phase 2
Details
Lead Sponsor:
Organisation for Oncology and Translational Research